UBS Group’s Orangekloud Technology Inc ORKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.96K Sell
3,882
-15
-0.4% -$17 ﹤0.01% 9118
2026
Q1
$4.05K Sell
3,897
-2,672
-41% -$2.66K ﹤0.01% 8998
2025
Q4
$4.47K Buy
6,569
+6,165
+1,526% +$8.18K ﹤0.01% 8832
2025
Q3
$836 Buy
404
+91
+29% +$250 ﹤0.01% 9528
2025
Q2
$638 Sell
313
-12,401
-98% -$26.8K ﹤0.01% 9773
2025
Q1
$35.7K Sell
12,714
-1,604
-11% -$9.26K ﹤0.01% 7833
2024
Q4
$173K Buy
+14,318
New +$214K ﹤0.01% 6539

Other funds holding ORKT

UBS Group's ORKT Position: Q2 2026 in Review

UBS Group reduced its Orangekloud Technology Inc (ORKT) stake by 0.38% in Q2 2026, selling an estimated $17 and leaving 3,882 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #9118.

UBS Group first reported a position in ORKT in Q4 2024 and has held it in 7 quarters since. The position peaked at $173K in Q4 2024. 8 funds tracked by Wall St. Rank hold ORKT as of Q2 2026.

  • UBS Group held 3,882 shares of Orangekloud Technology Inc worth $3.96K as of Q2 2026.
  • UBS Group sold 15 Orangekloud Technology Inc shares in Q2 2026, an estimated $17.
  • Orangekloud Technology Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9118 holding.
  • UBS Group first reported a position in Orangekloud Technology Inc in Q4 2024 and has held it in 7 quarters since.
  • UBS Group's Orangekloud Technology Inc position peaked at $173K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Orangekloud Technology Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.